Unlocking Safer, More Efficient Delivery to Targeted Brain Regions by Advancing Direct, & Systemic Delivery to the CNS Via TfR1 & Beyond
Despite milestones such as Roche’s Trontinemab Brainshuttle™ achieving robust amyloid clearance, challenges remain in reaching targeted brain regions, improving predictive modelling, ensuring efficacy and penetrance, and developing safer, targeted delivery approaches.
The summit joined 100+ industry experts spanning neuroscientists, chemists, device engineers, conjugation scientists, DMPK experts, delivery specialists, and more at the 7th CNS Drug Delivery Summit to collaborate, network, and learn cutting-edge strategies that are tackling the unique challenges in gaining access to the brain.
Attendees gained actionable insights from case studies, presentations, and deep-dive discussions on CNS drug delivery strategies covering systemic and local delivery, blood-brain barrier targeting, RMT modulation, and emerging modalities from Biogen, Sanofi, Merck, UCB, Eli Lilly, Alnylam, Voyager, and more, to advance brain access and accelerate CNS therapy development.
I see this conference as a great opportunity to connect with leading experts from industry and academia in the field of brain delivery. I am looking forward to meaningful discussions and a fruitful exchange on what we have already achieved, what the field is currently working on and how we will overcome the next challenges.
Urs Langen, Lab Head & Research Project Leader, Roche
An outstanding opportunity to hear great science, exchange ideas, and connect with fellow researchers in the community.
Sonu Kumar, Principal Scientist, Bristol Myers Squibb
The CNS Drug Delivery Summit provides a stimulating program, with extensive opportunities for one-on-one interactions with speakers and attendees. I’ve attended the past 5 summits and always leave with many important learnings, and glad that I decided to attend.
James Gorman, Principal Investigator, Brain Targeting Program, WYSS Institute, Harvard Medical School
This conference has connected me with other people who are passionate about drug delivery to the CNS and advancing treatments/technologies for patients.
Kaitlyn Eddy, Protein Engineer, Eli Lilly
Explore the Full Event Guide
- 25+ World Class Speakers with Cutting Edge Insights
- 10+ Hours of Face-to-Face Networking Opportunities
- 3 Days of Unmissable Data-Driven Content
- 2 Dedicated Tracks of Content Spanning CNS Biology, Platform & Tech, Chemistry, DMPK, BD & More for the Whole Team
![60515-brochure[1]](https://cns-drug-delivery.com/wp-content/uploads/sites/287/2024/08/60515-brochure1.png "60515-brochure[1]")
Official Partners
Attending Companies Include
Explore Related Events
![CB-CDx-0690-min-scaled111-768x511[1]](https://cns-drug-delivery.com/wp-content/uploads/sites/287/2024/06/CB-CDx-0690-min-scaled111-768x5111-1.jpg "CB-CDx-0690-min-scaled111-768x511[1]")
Explore the Agenda
Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 25+ expert speakers shaping the future of CNS drug delivery
![Untitled-1280-x-851-px-768x511[1]](https://cns-drug-delivery.com/wp-content/uploads/sites/287/2024/06/Untitled-1280-x-851-px-768x5111-1.png "Untitled-1280-x-851-px-768x511[1]")
Partner With Us
Showcase your solutions, connect with decision makers, and position your company as the go-to provider to CNS drug developers focused on brain delivery
![Untitled-1280-x-851-px-1-768x511[1]](https://cns-drug-delivery.com/wp-content/uploads/sites/287/2024/06/Untitled-1280-x-851-px-1-768x5111-1.png "Untitled-1280-x-851-px-1-768x511[1]")
Join Biopharma Experts
Network with pharma, biotech, diagnostics, academia, consortia, and regulatory voices driving real-world adoption